Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Megestrol Acetate Oral Suspension

Approval Number

国药准字HC20210002

Company

安成国际药业股份有限公司

Registration Date

May 8, 2021

Drug Information

Generic Name

醋酸甲地孕酮口服混悬液

Dosage Form

口服混悬剂

Strength

1ml：125mg（150ml/瓶）

Drug Type

化学药品

Registration Date

May 8, 2021

Expiry Date

May 7, 2026

Company Information

Applicant Company

Company Name

安成国际药业股份有限公司

Company Address

台北市114内湖区港墘路221巷41号4楼

Manufacturing Company

Company NameTWI PHARMACEUTICALS, INC. ZHONGLI PLANT

Company Address

台湾桃园市320中坜区自强四路3-1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy